Conavi Medical Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Net Income	-39.28	-43.62	-26.09	-11.87
Depreciation & Amortization	0.74	0.89	1.17	0.93
Other Amortization	0.13	0.09	0.12	0.16
Loss (Gain) From Sale of Assets	0.1	0.2	0.19	0.03
Asset Writedown & Restructuring Costs	0.23	0.09	0.03	0.06
Loss (Gain) From Sale of Investments	-	-	-0.13	-
Stock-Based Compensation	0.21	0.26	0.62	1.18
Other Operating Activities	10.59	17.61	3	-0.03
Change in Accounts Receivable	0.63	0.06	-0.5	0.04
Change in Inventory	2.25	1.39	-0.04	-0.23
Change in Accounts Payable	1.58	2.45	1.92	0.19
Change in Unearned Revenue	0.12	-0.22	0.18	0.02
Change in Other Net Operating Assets	0.39	0.63	-0.63	-0.33
Operating Cash Flow	-22.3	-20.15	-19.98	-8.85
Capital Expenditures	-0.32	-0.58	-0.69	-0.93
Sale (Purchase) of Intangibles	-0.1	-0.27	-0.14	-0.16
Investment in Securities	-	-	0.13	-
Investing Cash Flow	3.33	-0.85	-0.69	-1.09
Short-Term Debt Issued	-	8.19	-	-
Long-Term Debt Issued	-	-	0.41	-
Total Debt Issued	8.19	8.19	0.41	-
Long-Term Debt Repaid	-	-0.94	-1.43	-0.95
Net Debt Issued (Repaid)	7	7.26	-1.02	-0.95
Issuance of Common Stock	10.09	0.01	0	-
Financing Cash Flow	17.09	7.26	30.25	12.98
Net Cash Flow	-1.88	-13.73	9.58	3.04
Free Cash Flow	-22.62	-20.72	-20.66	-9.78
Free Cash Flow Margin	-236.29%	-958.95%	-874.07%	-362.22%
Free Cash Flow Per Share	-0.94	-3.36	-3.36	-1.59
Levered Free Cash Flow	-	-16.88	-14.69	-
Unlevered Free Cash Flow	-	-11.87	-11.16	-
Change in Net Working Capital	-	-4.13	-1.26	-

Updated Dec 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.